|
1
|
Alzheimer's A; Alzheimer's Association, :
2016 Alzheimer's disease facts and figures. Alzheimers Dement.
12:459–509. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cummings JL: Alzheimer's disease. N Engl J
Med. 351:56–67. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Scheltens P, Blennow K, Breteler MM, de
Strooper B, Frisoni GB, Salloway S and Van der Flier WM:
Alzheimer's disease. Lancet. 388:505–517. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jones RW, Romeo R, Trigg R, Knapp M, Sato
A, King D, Niecko T, Lacey L and Group DI; DADE Investigator Group,
: Dependence in Alzheimer's disease and service use costs, quality
of life, and caregiver burden: The DADE study. Alzheimers Dement.
11:280–290. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Atri A: The Alzheimer's Disease Clinical
Spectrum: Diagnosis and Management. Med Clin North Am. 103:263–293.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao MY, Wang GQ, Wang NN, Yu QY, Liu RL
and Shi WQ: The long-non-coding RNA NEAT1 is a novel target for
Alzheimer's disease progression via miR-124/BACE1 axis. Neurol Res.
41:489–497. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Millan MJ: Linking deregulation of
non-coding RNA to the core pathophysiology of Alzheimer's disease:
An integrative review. Prog Neurobiol. 156:1–68. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zou C, Wang J, Huang X, Jian C, Zou D and
Li X: Analysis of transcription factor- and ncRNA-mediated
potential pathogenic gene modules in Alzheimer's disease. Aging
(Albany NY). 11:6109–6119. 2019.PubMed/NCBI
|
|
9
|
Yang Y, Zhao L, Lei L, Lau WB, Lau B, Yang
Q, Le X, Yang H, Wang C, Luo Z, et al: LncRNAs: The bridge linking
RNA and colorectal cancer. Oncotarget. 8:12517–12532. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ge J, Geng S and Jiang H: Long noncoding
RNAs antisense noncoding RNA in the INK4 locus (ANRIL) correlates
with lower acute exacerbation risk, decreased inflammatory
cytokines, and mild GOLD stage in patients with chronic obstructive
pulmonary disease. J Clin Lab Anal. 33:e226782019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu Y and Hu J: Diagnostic value of
circulating lncRNA ANRIL and its correlation with coronary artery
disease parameters. Braz J Med Biol Res. 52:e83092019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wei JC, Shi YL and Wang Q: LncRNA ANRIL
knockdown ameliorates retinopathy in diabetic rats by inhibiting
the NF-κB pathway. Eur Rev Med Pharmacol Sci. 23:7732–7739.
2019.PubMed/NCBI
|
|
13
|
Guo Z, Li L, Gao Y, Zhang X and Cheng M:
Overexpression of lncRNA ANRIL aggravated hydrogen
peroxide-disposed injury in PC-12 cells via inhibiting
miR-499a/PDCD4 axis-mediated PI3K/Akt/mTOR/p70S6K pathway. Artif
Cells Nanomed Biotechnol. 47:2624–2633. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang H, Wang H, Shu Y and Li X: miR-103
promotes neurite outgrowth and suppresses cells apoptosis by
targeting prostaglandin-endoperoxide synthase 2 in cellular models
of Alzheimer's disease. Front Cell Neurosci. 12:912018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chai L, Yuan Y, Chen C, Zhou J and Wu Y:
The role of long non-coding RNA ANRIL in the carcinogenesis of oral
cancer by targeting miR-125a. Biomed Pharmacother. 103:38–45. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hsu AC, Dua K, Starkey MR, Haw TJ, Nair
PM, Nichol K, Zammit N, Grey ST, Baines KJ, Foster PS, et al:
MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation
and impair antiviral response in COPD. JCI Insight. 2:e904432017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang J, Yan F, Zhao Q, Zhan F, Wang R,
Wang L, Zhang Y and Huang X: Circulating exosomal miR-125a-3p as a
novel biomarker for early-stage colon cancer. Sci Rep. 7:41502017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kinney JW, Bemiller SM, Murtishaw AS,
Leisgang AM, Salazar AM and Lamb BT: Inflammation as a central
mechanism in Alzheimer's disease. Alzheimers Dement (N Y).
4:575–590. 2018.PubMed/NCBI
|
|
20
|
Attems J and Jellinger KA: The overlap
between vascular disease and Alzheimer's disease--lessons from
pathology. BMC Med. 12:2062014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luo Q and Chen Y: Long noncoding RNAs and
Alzheimer's disease. Clin Interv Aging. 11:867–872. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu J, Wang D, Wu H, Yang Z, Yang N and
Dong J: Long non-coding RNA ANRIL-mediated inflammation response is
involved in protective effect of rhein in uric acid nephropathy
rats. Cell Biosci. 9:112019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qiao C, Yang L, Wan J, Liu X, Pang C, You
W and Zhao G: Long noncoding RNA ANRIL contributes to the
development of ulcerative colitis by miR-323b-5p/TLR4/MyD88/NF-κB
pathway. Biochem Biophys Res Commun. 508:217–224. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu J, Wu H, Wang D, Yang Z and Dong J:
LncRNA ANRIL promotes NLRP3 inflammasome activation in uric acid
nephropathy through miR-122-5p/BRCC3 axis. Biochimie. 157:102–110.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wen X, Han XR, Wang YJ, Wang S, Shen M,
Zhang ZF, Fan SH, Shan Q, Wang L, Li MQ, et al: Down-regulated long
non-coding RNA ANRIL restores the learning and memory abilities and
rescues hippocampal pyramidal neurons from apoptosis in
streptozotocin-induced diabetic rats via the NF-κB signaling
pathway. J Cell Biochem. 119:5821–5833. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Feng L, Guo J and Ai F: Circulating long
noncoding RNA ANRIL downregulation correlates with increased risk,
higher disease severity and elevated pro-inflammatory cytokines in
patients with acute ischemic stroke. J Clin Lab Anal.
33:e226292019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Potenza N and Russo A: Biogenesis,
evolution and functional targets of microRNA-125a. Mol Genet
Genomics. 288:381–389. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu Q, Wang L, Yan G, Zhang W, Huan Z and
Li J: miR-125a-5p alleviates dysfunction and inflammation of
pentylenetetrazol-induced epilepsy through targeting
calmodulin-dependent protein kinase IV (CAMK4). Curr Neurovasc Res.
16:365–372. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ge Y, Sun M, Wu W, Ma C, Zhang C, He C, Li
J, Cong Y, Zhang D and Liu Z: MicroRNA-125a suppresses intestinal
mucosal inflammation through targeting ETS-1 in patients with
inflammatory bowel diseases. J Autoimmun. 101:109–120. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao X, Tang Y, Qu B, Cui H, Wang S, Wang
L, Luo X, Huang X, Li J, Chen S, et al: MicroRNA-125a contributes
to elevated inflammatory chemokine RANTES levels via targeting
KLF13 in systemic lupus erythematosus. Arthritis Rheum.
62:3425–3435. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Long HC, Wu R, Liu CF, Xiong FL, Xu Z, He
D, Zhang YF, Shao B, Zhang PA, Xu GY, et al: MiR-125a-5p regulates
vitamin D receptor expression in a mouse model of experimental
autoimmune encephalomyelitis. Neurosci Bull. 36:110–120. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mao D, Li H, Zhang L, Xu J, Yu C and Zhang
Q: Bilobalide alleviates IL-17-induced inflammatory injury in ATDC5
cells by downregulation of microRNA-125a. J Biochem Mol Toxicol.
33:e224052019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dong Y, Li P, Ni Y, Zhao J and Liu Z:
Decreased microRNA-125a-3p contributes to upregulation of p38 MAPK
in rat trigeminal ganglions with orofacial inflammatory pain. PLoS
One. 9:e1115942014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tian H, Ye X, Hou X, Yang X, Yang J and Wu
C: SVCT2, a potential therapeutic target, protects against
oxidative stress during ethanol-induced neurotoxicity via JNK/p38
MAPKs, NF-κB and miRNA125a-5p. Free Radic Biol Med. 96:362–373.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Park Y and Kim J: Regulation of IL-6
signaling by miR-125a and let-7e in endothelial cells controls
vasculogenic mimicry formation of breast cancer cells. BMB Rep.
52:214–219. 2019. View Article : Google Scholar : PubMed/NCBI
|
